Factors affecting recurrence in node-negative advanced gastric cancer

被引:53
作者
Huang, Kuo-Hung [1 ]
Chen, Jen-Hao [1 ]
Wu, Chew-Wun [1 ]
Lo, Su-Shun [1 ]
Hsieh, Mao-Chih [1 ]
Li, Anna F-Y [2 ]
Lui, Win-Yiu [1 ]
机构
[1] Taipei Vet Gen Hosp, Dept Surg, Taipei 11217, Taiwan
[2] Taipei Vet Gen Hosp, Dept Pathol, Taipei 11217, Taiwan
关键词
advanced gastric adenocarcinoma; node-negative; R0; resection; recurrent pattern; PROGNOSTIC-FACTORS; TUMOR SIZE; INDICATORS; CARCINOMA; SURVIVAL; INVASION; PATTERNS; STROMA;
D O I
10.1111/j.1440-1746.2009.05844.x
中图分类号
R57 [消化系及腹部疾病];
学科分类号
100201 [内科学];
摘要
Background and Aim: Prognostic factors of lymph node-negative gastric adenocarcinoma after curative resection have been discussed. Recurrent pattern of advanced lymph node-negative gastric cancer after curative resection has rarely been described. Methods: Recurrent sites and correlated clinicopathological factors of 372 patients with lymph node-negative advanced gastric adenocarcinoma that underwent R0 resection from 1988 to 2005 were analyzed. Results: Recurrence was noted in 51 (13.7%) patients. Recurrent rates according to site of recurrence were 26 peritoneal seeding (51.0%), 26 locoregional (51.0%), 17 hematogenous (33.3%), and 4 lymph node metastasis (7.8%). Clinicopathological factors to predict peritoneal seeding were serosal exposure, lymphovascular invasion, Lauren's diffuse type differentiation and scirrhous stromal reaction. Serosal exposure, tumor size, microscopic infiltrating growth type predicts locoregional recurrence. Tumor had only lymphovascular invasion predict hematogenous spreading. Conclusion: Node-negative advanced gastric cancer has more peritoneal seeding and locoregional recurrence. Aggressive cell behavior predicted the route of tumor cell spreading.
引用
收藏
页码:1522 / 1526
页数:5
相关论文
共 25 条
[1]
Adachi Y, 1997, J AM COLL SURGEONS, V184, P373
[2]
Bruno L, 2000, J SURG ONCOL, V74, P30, DOI 10.1002/1096-9098(200005)74:1<30::AID-JSO7>3.0.CO
[3]
2-2
[4]
Loss of E-cadherin expression correlates with poor differentiation and invasion into a acent organs in gastric adenocarcinomas [J].
Chen, HC ;
Chu, RY ;
Hsu, PN ;
Hsu, PI ;
Lu, JY ;
Lai, KH ;
Tseng, HH ;
Chou, NH ;
Huang, MS ;
Tseng, CJ ;
Hsiao, M .
CANCER LETTERS, 2003, 201 (01) :97-106
[5]
Harrison LE, 2000, J SURG ONCOL, V73, P153, DOI 10.1002/(SICI)1096-9098(200003)73:3<153::AID-JSO8>3.0.CO
[6]
2-4
[7]
Tumor stroma-associated antigens for anti-cancer immunotherapy [J].
Hofmeister, V ;
Vetter, C ;
Schrama, D ;
Bröcker, EB ;
Becker, JC .
CANCER IMMUNOLOGY IMMUNOTHERAPY, 2006, 55 (05) :481-494
[8]
Prognostic significance of metastatic lymph node ratio in T3 gastric cancer [J].
Hyung, WJ ;
Noh, SH ;
Yoo, CH ;
Huh, JH ;
Shin, DW ;
Lah, KH ;
Lee, JH ;
Choi, SH ;
Min, JS .
WORLD JOURNAL OF SURGERY, 2002, 26 (03) :323-329
[9]
Hyung WJ, 2002, ANN SURG ONCOL, V9, P562
[10]
Japanese Gastric Cancer Association, 1998, Gastric Cancer, V1, P10